AlphaMaven AlphaMaven

Mutares carves out AmeriTerpenes from Symrise

Reported by Pehub
Sep 1, 2026· 2 min read
Save Post LinkedIn Email
Key Takeaways
  • • Mutares is executing a carve-out of AmeriTerpenes, a specialty ingredient business, from Symrise, establishing an independent platform in the natural terpene market.
  • • AmeriTerpenes generates approximately $200 million in annual revenue, producing natural terpene-based ingredients derived from pine feedstocks for use across perfume, personal care, and food and beverage sectors.
  • • The transaction represents a strategic portfolio restructuring by Mutares, the Munich-based buyout firm, to establish a standalone operating entity focused on the specialty chemicals and natural ingredients segment.
Summary
Mutares is carving out AmeriTerpenes from Symrise, creating an independent business unit focused on the production and distribution of natural terpene-based specialty ingredients. AmeriTerpenes, which generated approximately $200 million in revenue, manufactures terpene products derived from pine feedstocks for three primary end markets: perfume and fragrance, personal care products, and food and beverage applications.

The separation establishes AmeriTerpenes as a distinct platform capable of operating independently within Mutares' portfolio of specialty chemical and ingredient businesses. By isolating the business from Symrise's broader operations, the carve-out allows AmeriTerpenes to pursue targeted growth strategies in the natural ingredients segment, where demand for sustainable, plant-based raw materials continues to expand across consumer and industrial applications.

This transaction aligns with Mutares' broader strategy of acquiring underperforming divisions or spin-outs from larger corporates and repositioning them as focused, growth-oriented platforms. The natural terpenes market benefits from secular trends toward naturality and sustainability in fragrance, personal care, and food industries, positioning AmeriTerpenes to capitalize on these dynamics as an independent operator.

Go deeper than the headline

Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.

Start your free 7-day trial

Sources

1 outlet

AlphaMaven summarised this story from the reporting below. Each link opens the original article.

Pehub Mutares carves out AmeriTerpenes from Symrise